Wed, Apr 23, 2014, 10:52 AM EDT - U.S. Markets close in 5 hrs 8 mins

Recent

% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

  • surfer_bj surfer_bj Aug 9, 2013 2:10 PM Flag

    PTX HUGE Uside Potential

    Hope you shorts shorted the daylights out of PTX on recent downgrade and your in a good mood today......Why do you think PTX and other companies get downgraded after all the negative news has been said and done and are already near their yearly lows? Makes analyst feel they are smart catching a falling stock.

    But what some Analyst are really telling you, this is near the bottom and my followers want a little bit more better price, this makes me look smart! Why wasn't PTX downgraded before the last quarter results or right after. It's after the fact, now its time for PTX to move forward.

    I am no analyst, but predict PTX stock and earnings will be much higher next quarter with a "Strong Buy" rating. Why because they have consumed the negatives from the last company purchases. Sales $ are UP. More CASH and future will look much better. With that said, goodbye shorts, and hello a stronger PTX with a new $20 Mil cash and
    $10 Million in 2 payments over the next 2 years.

    For the second quarter 2013, net sales increased by approximately 96% to $20.6 million, compared to $10.5 million for the same period in the prior year. The growth in net revenues was due primarily to sales of branded and generic products acquired from Cypress Hawthorn and Silenor products acquired in the merger with Somaxon.

    As of June 30, 2013, the Company had $9.0 million of cash and cash equivalents. The Company reaffirms its previously announced net revenue guidance for the full year 2013 to be in the range of $90 to $100 million. In the second half of 2013, the Company expects to record higher net revenues in the fourth quarter than the third quarter.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I am not short PTX and agree that it is finally may be getting interesting at these levels? but what is a company worth that hasn't made money in quite some time and every product they have acquired or partnered with has performed well below expectations. I think Managements strategy of growth at any cost has been misguided. Slower, but Profitable growth would have been far better for shareholders. Lots of analysts had touted this stock at much higher levels, I think their credibility is blown. Could be worth 1x rev's until they return to profitability, jmvho. But admittedly, thats just a guess.

    • Wait until Silenor gets the 1mg OTC approval and sales will soar. In my opinion this is a $12 to $14 stock.

      Sentiment: Strong Buy

    • The MM's ran it down to short. With some good news this stock is only going up....bought more today.

      Sentiment: Buy

 
PTX
5.01+0.11(+2.24%)10:52 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.